New Report: LIFT-TB Helped Cut Time to Global Uptake of Improved Drug-Resistant TB Treatments from Nearly a Decade to Three Years
Country-led evidence and implementation support enabled faster adoption of shorter, more effective regimens worldwide SEOUL…
TB Alliance Congratulates Bruce Carter on His Appointment as an Officer of the Order of the British Empire
TB Alliance warmly congratulates Bruce Carter, PhD, on his appointment as an Officer of the…
Doris Macharia Elected President of TB Alliance’s Global TB Stakeholders, Joins Board of Directors
Global health leader brings deep expertise in advancing children’s health, HIV, and global health equity…
TB Alliance Announces New Collaboration with Novartis to Advance the Research and Development of Telacebec for Leprosy
New collaboration aims to advance innovation for a neglected and stigmatizing disease affecting hundreds of…
TB Alliance and Lupin Announce Collaboration to Advance and Commercialize Telacebec for Multiple Neglected Diseases
Partnership will support the development of investigational drug telacebec for the treatment of tuberculosis, leprosy,…
TB Alliance and Asian Development Bank Forge Strategic Partnership to Strengthen Regional Efforts Against Tuberculosis
New York, USA and Manila, Philippines — [Date] — TB Alliance and the Asian Development…
Making Medicines Easier to Take: XTEMP-R Benefits More than Children with TB
For many children, and plenty of adults, swallowing tablets is hard. Ready-made syrups are often…
Promising New Data on Pediatric Use of Pretomanid in Children with Drug-Resistant Tuberculosis Presented at 2025 Union Conference
Positive results mark an important step forward in efforts to develop effective treatments for children…
Phase 2 Clinical Trial Results Show Potential to Shorten TB Treatment Time
Thuto Pulane, a TB survivor and participant in the NC-009 trial, at a follow-up appointment…